EREG and breast cancer: Somatic mutation in cancer based on copy number, aberrations, nucleotide substitutions, and on subsets in breast cancer BRCA1/2 are found by dGene, DGIdb HER2, and ESR1 estrogen receptor (ER) gene mutations for finding a drug or kinase inhibitor.